ANVS - Annovis Bio, Inc.

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 5.18

Open

$ 5.58

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 4.96 - $ 5.64

52 Week Range

$ 4.86 - $ 22.49

Volume

606,321

Average Volume

Market Cap

46.74M

Beta (5Y Monthly)

$ 1.63

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-29-2024	12-31-2023	10-K
2	11-08-2023	09-30-2023	10-Q
3	08-14-2023	06-30-2023	10-Q
4	05-10-2023	03-31-2023	10-Q
5	03-31-2023	12-31-2022	10-K
6	11-08-2022	09-30-2022	10-Q
7	08-08-2022	06-30-2022	10-Q
8	05-04-2022	03-31-2022	10-Q
9	03-02-2022	12-31-2021	10-K
10	11-03-2021	09-30-2021	10-Q
11	07-28-2021	06-30-2021	10-Q
12	05-06-2021	03-31-2021	10-Q
13	03-03-2021	12-31-2020	10-K
14	11-04-2020	09-30-2020	10-Q
15	07-29-2020	06-30-2020	10-Q
16	05-05-2020	03-31-2020	10-Q
17	03-25-2020	12-31-2019	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
04/30/2024 16:31:18

Canaccord Genuity Maintains Buy on Annovis...
04/30/2024 12:02:53

Canaccord Genuity analyst Sumant Kulkarni maintains Annovis Bio (NYSE:ANVS) with a Buy and lowers the price target from $36 ...

HC Wainwright & Co. Reiterates Buy on Anno...
04/30/2024 10:25:09

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Annovis Bio (NYSE:ANVS) with a Buy and maintains $30 price tar...

S&P 500 Edges Higher; ON Semiconductor Ear...
04/29/2024 18:34:41

why-is-alzheimers-focused-annovis-bio-stock-nosediving-on-monday

Why Is Alzheimer's-Focused Annovis Bio Sto...
04/29/2024 17:53:27

Annovis Bio faces setbacks in Phase 2/3 Alzheimer's study, revealing minimal change in patients' conditions. Despite sl...

Why Clever Leaves Holdings Shares Are Trad...
04/29/2024 17:04:01

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
04/29/2024 16:31:20

Annovis Bio Shares Halted On Circuit Break...
04/29/2024 15:53:10

Annovis Bio Shares Halted On Circuit Break...
04/29/2024 15:36:07

Annovis Bio Shares Halted On Circuit Break...
04/29/2024 15:18:53

Annovis Bio Shares Halted On Circuit Break...
04/29/2024 14:52:34

Annovis Bio Shares Halted On Circuit Break...
04/29/2024 14:46:51

Annovis Bio Shares Resume Trading
04/29/2024 14:46:33

Annovis Bio Shares Halted On Circuit Break...
04/29/2024 14:45:48

Annovis Bio Shares Halted On Circuit Break...
04/29/2024 14:36:31

Annovis Bio Shares Resume Trade
04/29/2024 14:35:50

Annovis Bio Shares Halted On Circuit Break...
04/29/2024 14:34:44

Annovis Bio Says Buntanetap Is Safe And We...
04/29/2024 14:16:08

Annovis Bio Announces Statistically Signif...
04/29/2024 14:15:16

Significantly higher rate of improvement in ADAS-Cog 11 scores in each treatment dose relative to placebo for patients with mil...

Annovis Bio Shares Halted, News Pending
04/29/2024 13:49:31